Darnytsia Registers Antibacterial Agent in Bosnia and Herzegovina for the Treatment and Prevention of Infectious Diseases

Darnytsia Pharmaceutical Company has registered an antibacterial medicinal product in Bosnia and Herzegovina for systemic treatment and prevention of infectious diseases.

Although Bosnia and Herzegovina is not an EU member, the regulatory rules in this country are strict, and the requirements for the quality and efficacy of medicines are high. The registration of Darnytsia's medicinal product in this country once again confirms that Ukrainian medicines are on par with foreign ones.

Recently, a Darnytsia medicine for the local treatment of acute inflammatory diseases of the oral cavity and throat was successfully registered in Moldova.

It is worth noting that Darnytsia's high-quality and safe medicines are already trusted in 20 countries worldwide.

"We continue to move forward, offering new and innovative Darnytsia medicines in various countries. The quality and safety of our products meet both global pharmaceutical standards and the needs of patients. Therefore, our medicines are trusted. This gives us the green light to expand our sales markets and motivates us to achieve new accomplishments," says Anna Pavliuk-Havrylova, Head of the Department of International Registration and Market Expansion at Darnytsia Pharmaceutical Company.